estradiol + progesterone
Phase 2- Indications
- Menopause, Vasomotor symptoms
Company intelligence / Profile preview
Centro A.F. de Estudios Tecnológicos (CAFET) is the pharmaceutical research and technology development arm associated with Laboratorios Carnot in Mexico. The organization was created in 1989 to develop innovative pharmaceutical products, formulation technologies, analytical methods, bioavailability capabilities, clinical research support, and manufacturing-related engineering solutions for Carnot's portfolio. CAFET appears to function primarily as an internal and external applied R&D organization rather than a venture-backed biotech with a disclosed therapeutic pipeline. Its work spans pharmaceutical technology, analytical chemistry, biopharmaceutics, clinical research, packaging innovation, and patent generation, and Carnot states that technologies developed by CAFET have resulted in dozens of patents recognized across Latin America, the United States, Europe, and Asia. Overall, CAFET should be viewed as a health-related pharmaceutical R&D company/platform embedded within the broader Carnot organization, not as a standalone clinical-stage biotech focused on novel molecular targets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Centro A.F. de Estudios Tecnologicos.